Literature DB >> 15562155

Why we should allow performance enhancing drugs in sport.

J Savulescu1, B Foddy, M Clayton.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15562155      PMCID： PMC1724991          DOI： 10.1136/bjsm.2003.005249

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN： 0306-3674            Impact factor:   13.800


× No keyword cloud information.
  14 in total

Review 1.  Normal ranges for packed cell volume and hemoglobin concentration in adults: relevance to 'apparent polycythemia'.

Authors:  V F Fairbanks; A Tefferi
Journal:  Eur J Haematol       Date:  2000-11       Impact factor: 2.997

2.  A global strategy for prevention and detection of blood doping with erythropoietin and related drugs.

Authors:  M Cazzola
Journal:  Haematologica       Date:  2000-06       Impact factor: 9.941

3.  A strategy to deter blood doping in sport.

Authors:  Michael J Ashenden
Journal:  Haematologica       Date:  2002-03       Impact factor: 9.941

4.  What price the Olympian ideal?

Authors:  A Abbott
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

5.  Haemoglobin, haematocrit and red blood cell indices in elite cyclists. Are the control values for blood testing valid?

Authors:  Y O Schumacher; D Grathwohl; J M Barturen; M Wollenweber; L Heinrich; A Schmid; G Huber; J Keul
Journal:  Int J Sports Med       Date:  2000-07       Impact factor: 3.118

Review 6.  Use and abuse of anabolic and other drugs for athletic enhancement.

Authors:  D H Catlin; C K Hatton
Journal:  Adv Intern Med       Date:  1991

7.  Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal exercise.

Authors:  Gabrielle Russell; Christopher J Gore; Michael J Ashenden; Robin Parisotto; Allan G Hahn
Journal:  Eur J Appl Physiol       Date:  2002-01-11       Impact factor: 3.078

8.  Effect of beta blockade and beta stimulation on stage fright.

Authors:  C O Brantigan; T A Brantigan; N Joseph
Journal:  Am J Med       Date:  1982-01       Impact factor: 4.965

Review 9.  Effects of androgenic-anabolic steroids in athletes.

Authors:  Fred Hartgens; Harm Kuipers
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

10.  Haematocrit, hypertension and risk of stroke.

Authors:  G Wannamethee; I J Perry; A G Shaper
Journal:  J Intern Med       Date:  1994-02       Impact factor: 8.989
View more
  25 in total

Review 1.  Globalisation of anti-doping: the reverse side of the medal.

Authors:  Bengt Kayser; Aaron C T Smith
Journal:  BMJ       Date:  2008-07-04

Review 2.  Bioconservatism, bioliberalism, and the wisdom of reflecting on repugnance.

Authors:  Rebecca Roache; Steve Clarke
Journal:  Monash Bioeth Rev       Date:  2009-03

Review 3.  Should performance-enhancing drugs in sport be legalized under medical supervision?

Authors:  Urban Wiesing
Journal:  Sports Med       Date:  2011-02-01       Impact factor: 11.136

4.  A philosophical debate on the morality of doping is interesting but beyond the scope of our meta-analysis.

Authors:  Nikos Ntoumanis; Johan Y Y Ng; Vassilis Barkoukis; Susan Backhouse
Journal:  Sports Med       Date:  2015-03       Impact factor: 11.136

5.  Doping use meta-analysis: science seasoned with moralistic prejudice.

Authors:  Ognjen Arandjelović
Journal:  Sports Med       Date:  2015-03       Impact factor: 11.136

6.  Critical Realism and Empirical Bioethics: A Methodological Exposition.

Authors:  Alex McKeown
Journal:  Health Care Anal       Date:  2017-09

7.  The Landscape of the "Spirit of Sport" : A Systematic Review.

Authors:  Mojisola Obasa; Pascal Borry
Journal:  J Bioeth Inq       Date:  2019-08-23       Impact factor: 1.352

Review 8.  Neurodoping: brain stimulation as a performance-enhancing measure.

Authors:  Nick J Davis
Journal:  Sports Med       Date:  2013-08       Impact factor: 11.136

Review 9.  Prevalence of doping use in elite sports: a review of numbers and methods.

Authors:  Olivier de Hon; Harm Kuipers; Maarten van Bottenburg
Journal:  Sports Med       Date:  2015-01       Impact factor: 11.136

10.  A Thomistic appraisal of human enhancement technologies.

Authors:  Jason T Eberl
Journal:  Theor Med Bioeth       Date:  2014-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.